Gene · 8720
Papers2,858
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,858
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunocompromised Status Definition in Observational Studies Using Electronic Health Records: A Scoping Review and a Proposal for a Phenotype Identification Algorithm. | Pharmacoepidemiol Drug Saf | 2026 | 41902365 | PubTator, text mining | PubMed |
| Causal association of genetically predicted 1400 blood metabolites with inflammatory bowel disease risk: A Mendelian randomization study. | Medicine (Baltimore) | 2026 | 41894296 | PubTator, text mining | PubMed |
| Extracellular Vesicles Associated Metabolites as Intercellular Signalling Mediators in Disease and Therapy. | Metabolites | 2026 | 41893356 | PubTator, text mining | PubMed |
| Fluoxetine Reshapes Macrophage Membrane Sphingolipids and Inflammatory Response Without Affecting Extracellular Vesicle Biogenesis upon Inactivated SARS-CoV-2 Stimulation. | Membranes (Basel) | 2026 | 41893283 | PubTator, text mining | PubMed |
| Precision Medicine in Inflammatory Bowel Disease: The Emerging Role of Metabolic Dysfunction. | J Pers Med | 2026 | 41893007 | PubTator, text mining | PubMed |
| ORMDL3: from an asthma susceptibility gene to multi-disease associations. | Front Genet | 2026 | 41884618 | PubTator, text mining | PubMed |
| SiO2 dust induces the transformation of lung fibroblasts to myofibroblasts by activating the S1P-RhoA-YAP signaling pathway. | Toxicol In Vitro | 2026 | 41881086 | PubTator, text mining | PubMed |
| 2- and 4-quinolones as emerging anticancer scaffolds: Recent synthetic developments, SAR insights, and mechanistic perspective. | Eur J Med Chem | 2026 | 41880836 | PubTator, text mining | PubMed |
| Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension study. | J Neurol | 2026 | 41879928 | PubTator, text mining | PubMed |
| Sphingosine-1-phosphate promotes CD8 T cell exhaustion in breast cancer via exosomal transfer of TGFBR2. | Cell Death Dis | 2026 | 41872131 | PubTator, text mining | PubMed |
| KLF2 overrides the resident memory CD8 T cell differentiation program, in opposition to KLF3. | Proc Natl Acad Sci U S A | 2026 | 41871244 | PubTator, text mining | PubMed |
| Molecular mechanisms of exercise-induced improvements in Alzheimer's disease: a focus on lipid homeostasis. | Transl Neurodegener | 2026 | 41866584 | PubTator, text mining | PubMed |
| Plasma metabolomic profiling reveals lipid biomarkers for early detection of exercise-induced myocardial ischemia. | Medicine (Baltimore) | 2026 | 41861189 | PubTator, text mining | PubMed |
| Sphingosine‑1‑phosphate receptor 1 enhances olfactory receptor 51E1‑mediated inhibition of proliferation via Src/JNK signaling in prostate cancer cells. | Oncol Rep | 2026 | 41860044 | PubTator, text mining | PubMed |
| Mechanistic insights and therapeutic potential of sphingosine‑1‑phosphate in the development of pulmonary fibrosis (Review). | Mol Med Rep | 2026 | 41860030 | PubTator, text mining | PubMed |
| S1P-S1PR1 signaling impairs CD8+ T cell metabolism and effector function in tumors. | EMBO Rep | 2026 | 41857410 | PubTator, text mining | PubMed |
| International Expert Opinion on Optimal Switching to Cladribine Tablets from Other High-Efficacy Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: Opportunities and Challenges. | Neurol Ther | 2026 | 41854800 | PubTator, text mining | PubMed |
| Combined high-intensity interval training and spirulina supplementation synergistically improve inflammatory and lipid-associated biomarkers in men with obesity. | Nutr Res | 2026 | 41850008 | PubTator, text mining | PubMed |
| S1P-sPRR axis in renal ischemia-reperfusion injury: inflammation via a cut. | Clin Sci (Lond) | 2026 | 41847947 | PubTator, text mining | PubMed |
| Sphingosine 1-Phosphate Receptor 1 and 5 Reciprocally Regulate IL-13 and IL-9 Production in Atopic Dermatitis. | Allergy | 2026 | 41845586 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8720/papers?page=3